Citadel Advisors’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.51M Buy
94,800
+67,500
+247% +$3.66M ﹤0.01% 4188
2025
Q4
$1.26M Sell
27,300
-3,100
-10% -$139K ﹤0.01% 6901
2025
Q3
$1.1M Sell
30,400
-52,600
-63% -$1.74M ﹤0.01% 7341
2025
Q2
$2.7M Buy
83,000
+32,500
+64% +$1.07M ﹤0.01% 5158
2025
Q1
$1.91M Buy
50,500
+15,500
+44% +$1.24M ﹤0.01% 5624
2024
Q4
$2.87M Buy
35,000
+5,100
+17% +$506K ﹤0.01% 4917
2024
Q3
$3.42M Buy
29,900
+9,800
+49% +$883K ﹤0.01% 4565
2024
Q2
$1.52M Sell
20,100
-13,700
-41% -$933K ﹤0.01% 5827
2024
Q1
$2.31M Buy
33,800
+27,000
+397% +$1.87M ﹤0.01% 5244
2023
Q4
$427K Buy
6,800
+800
+13% +$41.5K ﹤0.01% 8438
2023
Q3
$306K Sell
6,000
-1,100
-15% -$54.3K ﹤0.01% 9132
2023
Q2
$355K Sell
7,100
-200
-3% -$9.48K ﹤0.01% 8675
2023
Q1
$274K Sell
7,300
-158,100
-96% -$6.71M ﹤0.01% 9558
2022
Q4
$7.93M Sell
165,400
-18,100
-10% -$710K 0.01% 3149
2022
Q3
$4.4M Sell
183,500
-500
-0.3% -$12.7K 0.01% 4086
2022
Q2
$4M Buy
184,000
+172,400
+1,486% +$3.99M 0.01% 4210
2022
Q1
$280K Sell
11,600
-600
-5% -$13.1K ﹤0.01% 10748
2021
Q4
$290K Sell
12,200
-800
-6% -$18.6K ﹤0.01% 11004
2021
Q3
$330K Buy
13,000
+1,700
+15% +$41.2K ﹤0.01% 10859
2021
Q2
$254K Buy
+11,300
New +$231K ﹤0.01% 11663

Other funds holding PCVX